Cell and Gene Covers 2026 ISPE Facility of the Year Awards (FOYA) Category Winner, AstraZeneca
16 July, 2026
AstraZeneca’s fully electrified Cell Therapy Facility in Rockville, Maryland represents a major leap in sustainable, resilient, and patient‑centric manufacturing. As described in the article that follows from Cell & Gene, the site was engineered to run 24/7 on electricity rather than natural gas—a bold shift in an industry where steam‑based sterilization and other heat‑intensive processes traditionally depend on fossil fuels. The facility was designed to produce thousands of autologous cell therapy doses annually, and its combination of electrification, reliability, and patient‑specific manufacturing earned AstraZeneca a 2026 ISPE FOYA Category Winner for Social Impact – Unmet Medical Need.
This honor was announced at the https://ispe.org/conferences/2026-europe-annual-conference2026 ISPE Europe Annual Conference in Copenhagen, Denmark. The Overall FOYA Winner will be announced at the https://ispe.org/conferences/2026-annual-meeting-expo/foya-banquet-and-awards-celebration?utm_source=PRNewswire&utm_medium=Press-Release&utm_campaign=26AM-ExecChair on 18 October, taking place during at https://ispe.org/conferences/2026-annual-meeting-expo in Washington, D.C., USA.
Learn more about the 2026 ISPE FOYA Banquet and Awards Celebration
Learn more about the 2026 ISPE Annual Meeting & Expo
About Cell & Gene
Cell & Gene delivers in-depth content about cell and gene therapies from experienced professionals in the field. This publication focuses exclusively on this segment of the life sciences industry.